Do You Need a License to Sell Peptides in South Carolina?

There is no single "peptide license" issued anywhere, South Carolina included. What applies to your business depends on which lane you operate in: standard business registration and tax accounts apply to essentially any company selling goods; distributing prescription drugs generally pulls a business into state drug-distributor or wholesaler permitting administered through pharmacy regulators; and reselling research-use-only (RUO) compounds intended for laboratory work sits in a narrower lane with its own labeling and documentation expectations. Which lane you are in — and what each one requires in your state — is a question to resolve with a South Carolina-licensed attorney and the relevant state board before you commit to inventory.

This article is informational and is not legal advice. It describes the questions to ask and the categories to sort yourself into, not a determination about your specific business.

The three lanes a peptide business can sit in

Most confusion about peptide licensing comes from collapsing three very different business models into one word: "selling." They are not the same activity, and they do not raise the same regulatory questions.

The first lane is general commerce. If you are forming an entity, collecting sales tax, and shipping goods, you are dealing with business registration, tax accounts, and possibly local licensing. This layer is not peptide-specific at all — it applies whether you sell reagents, skincare, or hardware.

The second lane is prescription drug distribution. Businesses that buy and resell FDA-approved prescription products generally encounter state wholesale distributor permitting, federal registration questions, licensed-personnel requirements, and pedigree or transaction-history recordkeeping. This is the most heavily regulated lane and the one where guessing is most expensive.

The third lane is research-use-only supply. RUO compounds are not FDA-approved drugs, are not sold for human or animal consumption, and are labeled for laboratory research only. Businesses reselling in this lane still face real obligations — accurate labeling, truthful marketing, documentation, and a hard line against making therapeutic claims — but the questions are different from those a prescription drug wholesaler answers.

Real Peptides supplies research-use-only compounds to business buyers. That means the relevant questions for a wholesale account are about the third lane, not the second — but only your own counsel can confirm which lane your particular model falls into, especially if your business also operates clinically.

Questions to bring to your attorney and the state board

Rather than looking for a rule that says "peptides are permitted," bring a short, specific list to a licensed attorney. The right questions save far more money than a generic answer ever will.

Ask which entity registrations and tax accounts your model triggers, and whether any county or municipal license applies where your business is domiciled. Ask whether the way you plan to describe, label, and market RUO compounds keeps you inside research-use framing — this is where most enforcement risk actually lives, because claims made in marketing copy can recharacterize a product regardless of what the label says. Ask whether anything about your intended activity would be viewed as distributing drugs rather than supplying research materials, and what would change that answer. Ask what records you should retain: supplier documentation, batch identifiers, certificates of analysis, and customer records.

If your business also holds clinical or professional licenses, ask separately how your board views the relationship between a licensed practice and a research-materials catalog. Those are two different regulatory conversations, and conflating them is a common mistake. State-level treatment of these questions varies, and requirements change, so a current answer from your attorney and the applicable board beats anything you read online — including this page.

What to verify in a supplier before opening an account

Once your side of the paperwork is sorted, the supplier becomes the variable you can actually control. In a market with a low barrier to entry, diligence on the supplier is diligence on your own brand, because their documentation becomes the documentation you hand your customers.

Start with purity and how it is measured. Ask for the analytical method, not just a number — high-performance liquid chromatography (HPLC) is the standard reference for peptide purity, and a stated purity figure without a method behind it is marketing. Then ask what else is tested. Purity alone says nothing about endotoxin, heavy metals, residual solvents, moisture content, or microbial load, and a single-assay certificate leaves most of the picture blank.

Ask whether certificates of analysis are batch-specific and whether you can see them without asking. Some suppliers treat COAs as a gated document, produce a generic sheet that never changes between lots, or charge for testing paperwork separately — all of which should end the conversation. Batch-level, independently verifiable documentation is the baseline, not a premium feature.

Ask where orders ship from and what the realistic fulfillment window is. Overseas transshipment introduces customs exposure and timeline variance you cannot explain away to your own customers. Finally, ask about pricing structure. Hidden pricing, quote-only tiers, and "call for wholesale" walls make it impossible to model your costs before you commit, and they usually mean pricing is negotiated case by case rather than published. Margins across this category vary widely with volume, compound, and how you position your catalog — anyone quoting you a specific margin figure for your business is guessing.

How wholesale tiers and minimums generally work

Wholesale programs in this category tend to price by volume band: as your committed order size increases, unit cost decreases, and access to broader catalog depth typically opens up. Minimum order quantities exist so the supplier can plan production and batch testing around real demand rather than one-off requests.

What matters more than the specific tier thresholds is whether they are published and stable. A program that tells you its structure up front lets you build a cost model, set your own pricing, and forecast reorders. A program that keeps everything behind a sales call makes your unit economics dependent on a negotiation you have to repeat.

The second variable is catalog breadth. Stocking a narrow set of well-documented compounds is usually a better starting position than trying to carry everything. Businesses building an initial catalog often anchor on widely studied research compounds — BPC-157 and GHK-Cu among them — before expanding into the wider popular peptides collection as reorder patterns become clear. Research into these compounds is ongoing and, in most cases, preclinical; studies suggest various mechanisms of interest, but nothing in a research catalog should ever be presented to your customers as a treatment, an outcome, or a therapy.

Labeling, records, and the discipline that keeps you clean

The operational habits that keep an RUO catalog defensible are unglamorous and easy to skip. Keep them anyway.

Every unit should carry research-use-only labeling that stays intact through your own repackaging or private labeling, if you do any. Product descriptions, email copy, social posts, and sales conversations all need to stay consistent with that labeling — a compliant label paired with non-compliant marketing copy is a compliance problem, not a technicality. Train anyone who talks to customers on where that line sits, and put it in writing.

Maintain batch traceability from supplier invoice to outbound order, so that if a question ever arises about a specific lot you can answer it in minutes rather than reconstructing it from memory. Keep the COA for every lot you receive, archived and retrievable. Keep your supplier's documentation on file even after inventory sells through.

None of this requires enterprise software at the start. A disciplined spreadsheet and a document folder are enough to demonstrate that you know what you sold, where it came from, and how it was tested.

What Real Peptides does differently

Real Peptides was built around the documentation problems above, and the program specifics are stated plainly rather than negotiated.

Compounds are produced to 99%+ HPLC purity. Every batch goes through 7-panel testing rather than a single purity assay, so the certificate covers more than one dimension of quality. Certificates of analysis are publicly verifiable — a prospective partner can review lab results directly before opening an account, and existing partners can point their own customers to the same documentation instead of promising that testing happened somewhere. That is the difference between a claim and a record.

Fulfillment runs from the United States, with typical delivery in 5–7 days, so partners are not building reorder timelines around customs. Wholesale pricing tiers are structured and disclosed to applicants rather than quoted ad hoc, and the wholesale peptides program uses a 3-step application: submit business details, get reviewed for qualification, and receive tier pricing and account access.

Every compound in the catalog is research use only, sold to businesses for laboratory research, and never offered or described for human consumption. Real Peptides does not supply semaglutide, tirzepatide, retatrutide, or Melanotan II through the program, and does not pair compounds with supplies in a way that implies a use kit. Those boundaries are part of what makes the program straightforward to diligence.

Where a qualified buyer goes from here

If you have confirmed your lane with counsel, sorted your registrations, and decided that batch-level documentation is non-negotiable for your brand, the remaining step is qualification. The Wholesale Partner Program review looks at your business details and returns tier pricing, so you can model costs before you order rather than after.

For more on the general framework and the questions worth raising with your attorney, see do you need a license to sell peptides, review the wholesale peptides program structure and published tiers, or apply for a wholesale account to begin the three-step qualification review.